Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,278 | -26,556 | -18,392 | -12,167 | -5,829 |
| Depreciation Amortization | 27 | 107 | 80 | 53 | 27 |
| Accounts receivable | 888 | 734 | 733 | 723 | 365 |
| Accounts payable and accrued liabilities | -1,155 | -3,887 | -3,892 | -2,168 | -2,937 |
| Other Working Capital | 228 | -1,907 | -2,314 | -1,238 | -2,108 |
| Other Operating Activity | 586 | 3,340 | 3,746 | 1,920 | 3,527 |
| Operating Cash Flow | $-7,705 | $-28,171 | $-20,038 | $-12,875 | $-6,955 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -7,316 | N/A | N/A | N/A |
| Purchase Of Investment | -75 | -330 | -255 | -150 | -75 |
| Investing Cash Flow | $-75 | $-7,646 | $-255 | $-150 | $-75 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 45,448 | 31,891 | 17,177 | 11,960 |
| Financing Cash Flow | $N/A | $45,448 | $31,891 | $17,177 | $11,960 |
| Beginning Cash Position | 10,494 | 862 | 862 | 862 | 862 |
| End Cash Position | 2,714 | 10,494 | 12,460 | 5,014 | 5,792 |
| Net Cash Flow | $-7,780 | $9,632 | $11,598 | $4,152 | $4,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,705 | -28,171 | -20,038 | -12,875 | -6,955 |
| Free Cash Flow | -7,705 | -28,171 | -20,038 | -12,875 | -6,955 |